Long-Term Dupilumab Efficacy on Severe Exacerbations and Lung Function in Patients with Type 2 Asthma

Ann Am Thorac Soc. 2024 Apr;21(4):675-679. doi: 10.1513/AnnalsATS.202306-544RL.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Asthmatic Agents* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma* / drug therapy
  • Double-Blind Method
  • Humans
  • Lung

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized
  • Anti-Asthmatic Agents